Targeting these downstream targets of DAPK-1 can alleviate stroke damage, obstruct the ability of Pin1 to activate oncogenic transcription factors, and suppress cell proliferation and tumor development [12,13,14]. The gene discussed is DAPK1; the disease is neoplasm.